Nations Financial Group’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$685K Sell
3,611
-15
-0.4% -$2.82K 0.03% 475
2026
Q1
$715K Sell
3,626
-33
-0.9% -$6.36K 0.04% 452
2025
Q4
$673K Buy
3,659
+974
+36% +$171K 0.04% 447
2025
Q3
$412K Buy
2,685
+106
+4% +$16K 0.03% 522
2025
Q2
$360K Hold
2,579
0.02% 522
2025
Q1
$379K Sell
2,579
-43
-2% -$6.22K 0.03% 487
2024
Q4
$344K Sell
2,622
-62
-2% -$8.68K 0.03% 521
2024
Q3
$418K Buy
2,684
+133
+5% +$21.5K 0.03% 490
2024
Q2
$398K Buy
2,551
+25
+1% +$3.76K 0.03% 469
2024
Q1
$342K Hold
2,526
0.03% 508
2023
Q4
$340K Hold
2,526
0.03% 489
2023
Q3
$342K Buy
+2,526
New +$345K 0.03% 468

Other funds holding AZN

Nations Financial Group's AZN Position: Q2 2026 in Review

Nations Financial Group reduced its AstraZeneca (AZN) stake by 0.41% in Q2 2026, selling an estimated $2.82K and leaving 3,611 shares worth $685K. The position accounts for 0.03% of the portfolio, ranked #475.

Nations Financial Group first reported a position in AZN in Q3 2023 and has held it in 12 quarters since. The position peaked at $715K in Q1 2026. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Nations Financial Group held 3,611 shares of AstraZeneca worth $685K as of Q2 2026.
  • Nations Financial Group sold 15 AstraZeneca shares in Q2 2026, an estimated $2.82K.
  • AstraZeneca made up 0.03% of Nations Financial Group's portfolio in Q2 2026, its #475 holding.
  • Nations Financial Group first reported a position in AstraZeneca in Q3 2023 and has held it in 12 quarters since.
  • Nations Financial Group's AstraZeneca position peaked at $715K in Q1 2026.
  • 443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Nations Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.